Organogenesis Holdings Inc.ORGO

Market cap

$655.83M

P/E ratio

	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	-	21	60	85	115	103	104	136
Total cash & short-term investments	-	-	21	60	85	115	103	104	136
Accounts receivable, net	-	-	34	39	57	82	89	82	110
Inventories	-	-	13	23	28	25	25	28	26
Total current assets	1	294,439	71	126	174	227	223	225	286
Property, plant and equipment, net	-	-	40	47	60	79	102	116	89
Total non-current assets	310	312	93	95	120	216	227	235	212
Total assets	311	313	164	221	294	443	449	460	498
Accounts payable	-	-	19	28	23	29	32	31	29
Total current liabilities	478,360	4	66	60	68	82	75	81	77
Total non-current liabilities	11	11	50	105	80	119	109	101	35
Total liabilities	11	15	117	165	148	201	184	181	113
Common stock and paid-in capital	-	-	0	0	0	0	0	0	0
Retained earnings	-233,860	-2,327,773	-130	-171	-153	-60	-45	-41	-40
Stockholders' equity	5	5	47	56	146	242	266	279	263
Working capital	-	-